Marijuana Sector News

0 3017

 

LEARN The Basics of How to Trade / Invest in the Stock Market (BEGINNERS ONLY)

 

We get hundreds of emails per day asking us how to invest in public MJ companies. Everyday our subscribers ask us how to start trading stocks. We’ve heard you loud and clear.

 


Click Here To Find Out More

 




$ADVT: New Bull Trend Confirmed?

 

 

Yesterday we updated everyone on our continuing coverage of ADVT. This was a sub penny when we began watching it a few months ago and since then, the recent trump bump seems to have taken hold. Yesterday the company announced that it is taking steps to become a fully-reporting public company.  During yesterday’s trading session alone, ADVT gained over 20% and just like the last time we started to follow an MJ company like this, it could be just the beginning.

 


Click Here To View Full Release




#ICYMI: $GRWC Secures $450,000 in Bridge Financing focusing on the build out of its Smoke on the Water brand

 

Yesterday we published the latest news from GRWC which outlined the next step and financial commitment for their build out of Smoke on the Water. After 5 consecutive days of a downward trend, GRWC began to see a reversal, which could be the start of a turn-around on the chart. We’ll continue to keep you updated with more developments on this.

 


Click Here To View Full Release


 

The Green Organic Dutchman Holdings Ltd. Provides Shareholder Update And Announces $10 Million Non-Brokered Financing

 

It is with great pleasure that I address you today as shareholders of our company, The Green Organic Dutchman Holdings Ltd. (“TGOD”). Our Company has recently made major developments that I would like to report on. Additionally, I would like to announce a new financing.

 


Click Here To View Full Article

 


 

 

$MCIG Strengthens Share Structure Announces Shareholder Call

 

mCig Inc., ( OTCQB : MCIG ), a diversified company servicing the legal cannabis, hemp, and CBD markets, came into a significant agreement with several MCIG’s major shareholders to reduce its common stock by 60 million shares by converting those shares into 6 million Series A Preferred Stock with a minimum 2 year lock up agreement. Paul Rosenberg, MCIG’s Chief Executive Officer, has also agreed to cancel an additional 20 million underlying common shares to further reduce the outstanding shares.

 


Click Here To View Full Release


 

$HEMP Updates and Announcements

 

Hemp, Inc. ( OTC PINK : HEMP ) executives are pleased to update its shareholders on the booming industrial hemp industry across the globe and how it is set to stimulate the economy on a national and global scale. Bruce Perlowin, CEO of Hemp, Inc. says ramping up hemp production on American soil, in particular, will serve as a stimulus for many ancillary industries from packaging and distribution to logistics and marketing. “The industrial hemp industry creates a win-win for all,” says Perlowin. However, until the federal ban is lifted in the U.S., organizations and advocates continue to educate the public on hemp and its benefits.

 


Click Here For Full PR

 




 

 

Pursuant to an agreement between MAPH and Grow Condos, we were hired for a period of 30 days to publicly disseminate information about (GRWC) including on the Website and other media including Facebook and Twitter. We are being paid $50,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (GRWC) which we purchased in the open market. MAPH owns 6 million restricted common shares of HEMP Inc. and 2 million restricted common shares of MCIG Inc. We may buy or sell additional shares of (GRWC, HEMP, MCIG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 925

American Cannabis Company, Inc. Announces It Has Secured A Contract And Equity Stake With A New Client In The State Of Pennsylvania

American Cannabis Company, Inc. ( OTCQB : AMMJ ) (the “Company”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured its sixth client in the state of Pennsylvania. The Company will work with this client to strategically plan, deploy and remotely oversee the client’s retail dispensing, cultivation and infused product manufacturing operations within the city of Philadelphia. In addition to the Company’s consulting engagement, the Company will also be taking an equity interest in the client’s project and operations.

The Company will provide end-to-end solutions for this new client, which include operational planning activities, conceptual design work, application completion, deployment of operations and ongoing remote management. The Company expects to leverage this contract to secure additional revenues through long-term consulting agreements and potential future sales of ancillary products.

Terry Buffalo, CEO of American Cannabis Company, commented: “We are excited to be working with this particular client, as well as collaborating with them by taking an equity position in their business. The Company is actively exploring the development of hybrid relationships like this, that generate both consulting revenues and the opportunity for recurring profits from our equity interest. We feel that this new strategy will provide a beneficial long-term value to both our clients and our shareholders.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, Sohum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, “the art and science of agriculture in soil.”

For more information, please visit:

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.dabwerks.com

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

0 2504

 

$VNNYF ($VIN) to Acquire Majority Stake in Multinational Plant Breeder

On the heels of their latest announcement that Vinergy Resources has officially obtained a US ticker symbol and will commence trading on the OTCQB, Vinergy Resources Ltd. (CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce today that it has signed a Letter of Intent (LOI) to acquire up to 51% of a European multinational plant breeding company (“Target”). The Target has audited annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over CAD $2,000,000.

 


Click Here To View Full PR


 

More Conditions Could be Added to List to Obtain Medical Marijuana

Virginia’s Senate recently voted to broaden the use of cannabis oil for medical purposes after a deliberation that shifted into presidential drug usage, 1960s hippie culture, and the long list of possible side effects communicated on some TV pharmaceutical ads. The bill, co-sponsored by Sen. Jill Holtzman Vogel and Senator Barbara A. Favola, builds on legislation passed two years ago that was meant to make it easier for Virginians with serious forms of epilepsy to use the oils that come from cannabis.

 


Click Here To View Full Article


 

#ICYMI: Cannabidiol Oil Will Not Be Affected By DEA Rescheduling

Reports of hemp-based CBD medicine’s death have been highly exaggerated. That’s the word from several legal experts who say, despite a moment of industry-wide panic about the DEA’s filing of a memo with the federal register establishing a “final rule” on the internal classification of “marijuana extracts” the law regarding CBD and hemp has not changed. A memo from Folium Legal Counsel reflects this widespread interpretation of the law and the lack of negative impacts on the industry since the filing took effect.

 


Click Here To View Full Article


 

PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 2794

$VBIO Publishes Scientific Data on Discovery of Cannabinoid Glycosides

Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality Biopharma”, “Vitality”, or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the publication of a scientific manuscript that details internal research efforts including the discovery and production of cannabinoid glycosides.

 


Click Here To View Full PR


 

$VPRB LP is partnering with Alpha-Cat

VPR Brands, LP (OTC PINK: VPRB), entered into an exclusive distribution and sales agreement with Alpha-Cat, the creator of the AlphaPuff all in one deluxe smoker’s kit. VPR Brands will represent the patent pending innovative all in one Cannabis water pipe travel kit by strategically introducing it within its distribution pipeline, showcasing it at large cannabis / smoking trade events, and further working with Alpha-Cat to continuously innovate on this revolutionary concept.

 


Click Here To View Full PR


 


$MCIG Announces $200,000 Investment from CEO and CFO

mCig Inc., ( OTCQB : MCIG ), a diversified company servicing the legal cannabis, hemp, and CBD markets, announced today it has entered into legally binding subscription agreements with Paul Rosenberg, Chairman and Chief Executive Officer and Michael Hawkins, Chief Financial Officer for the issuance of 25,000 newly issued Series A Preferred shares each. Under the agreements Mr. Rosenberg and Mr. Hawkins will subscribe for and purchase directly or through their own beneficially owned and controlled special purpose vehicle 25,000 shares of Series A Preferred stock each for a total purchase price of $200,000 ($100,000 each), or $4.00 per share, which equates to $0.40 per common share in conversion. In addition to the Series A Preferred stock, Mr. Rosenberg and Mr. Hawkins will each receive a five year warrant for an equal amount of common shares at $0.75 per share.

 


Click Here To View Full PR


 

Cannabidiol Oil Will Not Be Affected By DEA Rescheduling

Reports of hemp-based CBD medicine’s death have been highly exaggerated. That’s the word from several legal experts who say, despite a moment of industry-wide panic about the DEA’s filing of a memo with the federal register establishing a “final rule” on the internal classification of “marijuana extracts” the law regarding CBD and hemp has not changed. A memo from Folium Legal Counsel reflects this widespread interpretation of the law and the lack of negative impacts on the industry since the filing took effect.

 


Click Here To View Full Article


 

 PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 2627




Get the Full Picture, View in a Browser

Get MJ News, Articles, Picks & Alerts Instantly. From Your Cell Phone Text the Word “MJSTOCKS” to 82257

Advocates in Indiana See Hope In Medical Cannabis Hearing


When the state Legislature allowed a Senate committee to hear testimony on an Indiana medical cannabis-related bill, enthusiasts saw…



Click Here To View Full Article



$MCIG Cannabis & CBD’s Revenue Net Positive



MCIG has reached an important inflection point of controlled expenses, improved off take, and overall profitability. It has signed minimum order quantity…



Click Here To View Full News



$FBEC Announces Exclusive Agreement with New Co-Packer NVE Pharmaceuticals Developer of Stacker 2


FBEC Worldwide, Inc. (FBEC), a lifestyle brand company with a focus on Healthy Hemp Energy™ & CBD infused consumer products, is pleased to announce that on January 5, 2017 FBEC Worldwide, Inc. entered a new co-packing agreement with NVE Pharmaceuticals, the manufacturer of Stacker 2.



Click Here To View Full News



$UBQU Pays Down $65,000 Debt since January 1st, 2016



Ubiquitech Pays Down $65,000 Debt since January 1st, 2016; Anticipates Continuing This Trend of Debt Repayment Throughout the Year…


Click Here To View Full News




0 2125

 


Get MJ News, Articles, Picks & Alerts Instantly. From Your Cell Phone Text the Word “MJSTOCKS” to 82257
 

Why Are Executive Positions In The Marijuana Industry So Popular For Women?

The number of women in executive positions in the marijuana industry is astonishing. According to a study of 632 marijuana executives conducted by the Marijuana Business Daily in 2015, women are in leadership positions in…

 


Click Here To View Full Article


 

Californians Fighting Delays Of Recreational Cannabis Use

California farms, sells, and consumes billions of dollars worth of cannabis. For more than ten years, medicinal cannabis cardholders have been able to purchase…

 


Click Here To View Full Article


 

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017 GW Pharmaceuticals plc (GWPH) (“GW” or “the Company”), a biopharmaceutical…

 


Click Here To View Full News


 

 

1 22651

Today is the final trading day of the year will definitely be one that investors will always remember. The market remains in the positive as companies are better positioned for success. From the advance of the Canadian marijuana industry to election of Donald Trump, there will be a lot for investors to watch next year. We would like to highlight some themes anticipated to play out over 2017.

Consolidation

One of the brightest spots of the marijuana industry in 2016 was the Canadian licensed medical marijuana producer sub-sector. In early December, Mettrum Health (MT.V)(MQTRF) and Canopy Growth (CGC.TO)(TWMJF) announced an agreement where Canopy Growth will gain all of the outstanding shares of Mettrum.

Keep your eyes on the marijuana industry as it is expected to see more deals like this over the next year. The possibility for increase consolidation makes these companies attractive investment opportunities: Aphiria (APH.V)(APHQF), Supreme (SL.V)(SPRWF), OrganiGram (OGI.V)(ORGMF), Emblem Corporation (EMC.V), and Aurora Cannabis (ACB.V)(ACBFF).

Transformation

The biotech sector will be one of the greatest recipients of the legal marijuana movement and recent sector weakness has created opportunities for investors.
GW Pharmaceuticals (GWPH) reported its second Stage Three Clinical trial in September for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). We continue to view GWPH as one of the top marijuana investments due to its capability to convert the cannabis industry through the development of treatments for sickness’ that don’t currently have an approved regimen.

Execution

From the financial structure, investors need to conduct with earnestness. We suggest incorporating some guidelines into your investment blueprint.

To end 2016, we want to highlight some of the stocks investors should watch during next year: Emblem Corporation (EMC.V)(EMMBF), Zoned Properties (ZDPY), Aphria (APHQF), Kush Bottles (KSHB), American Cannabis (AMMJ), Aurora (ACBFF), Reliq Healthcare (RQHTF), Zynerba Pharmaceuticals (ZYNE), OrganiGram (OG.V)(ORGMF), Arcturus Grothstar Tech (AGSTF), MassRoots (MSRT), VPR Brands (VPRB), CV Sciences (CVSI), mCig (MCIG), Canopy Growth (TWMJF)(CGC.TO), Medicine Man Tech (MDCL), GW Pharmaceuticals (GWPH), Lexaria (LXRP), Canabo Medical (CMM.V)(CAMDF), Mettrum Health (MT.V), and VinergyRes (VIN.CN).

We receive roughly 50-100 emails per day, 7 days per week 365 days per year asking the following;

How do I get started trading stocks specifically Marijuana Stocks?

In order to buy any kind of stock you need a brokerage account. You need to know how to fund that account and eventually how to properly place buy and sell orders and last but not lease how to read and understand level 2. We found a series of short videos on YouTube that we posted on our page that will help you get up and trading quickly so you can take advantage of the HOT Marijuana Stocks.

Learn how to get started trading stocks right here right now

What Marijuana Stocks are worth Buying?

We cover all publicly traded marijuana stocks on our website. From time to time we identify those that stand apart from the crowd, the cream of the crop. When we identify these companies, we begin taking steps to alert them to YOU our audience.

Speaking of MJ Stocks Worth Buying…

We believe investors need to focus their attention on the cannabis biotech sector RIGHT NOW. Recent political shifts are setting up a “perfect storm” scenario for the cannabis biotech sector. One biotech fund manager even said he thinks the entire sector is about to double. For this reason, we will be profiling a new cannabis biotech company that we will be sticking with long term. PLEASE read that AGAIN, we said LONG TERM. In other words, this will NOT be a “Day Trade.” Not a “quick flip”. For those that don’t know Biotech & Marijuana are two of the HOTTEST sectors right now and will ONLY continue to get BIGGER and BIGGER as technology & law/ regulations advances.

Before We Alert this New, Company You Need to do 2 Things;

Again, PLEASE read, Why Cannabis Biotech Needs to be in Your Portfolio Right Now Here

9 8083

The biotech sector may be one of the biggest beneficiaries of the legal cannabis movement.

In previous articles, we have been quite vocal about our bullish stance on the cannabis biotech sector. In the current US markets, we believe the greatest opportunity lies in biotech and the pharmaceutical production of cannabinoid and cannabis related drug treatments. And recent political shifts may have just created a perfect storm for cannabis biotech investors. Right now could be your greatest opportunity to consider adding cannabis biotech to your portfolio. And we aren’t the only ones who think so.

Todd Hagopian, manager of a biotech fund at Marketocracy, believes the biotech sector will benefit most from a Donald Trump Presidency. Todd is one of the most successful biotech investors in the market today. His returns have averaged 26.03% since starting his fund in 2011, which compares nicely to the S&P 500’s 11.58% return over the same period. Over the last five and three year periods, Todd Hagopian did better than the top U.S. Equity fund managers.

But why are we so bullish on cannabis biotech?

For over a year, analysts have been anticipating and factoring in a Hillary Clinton victory that sent the ishares NASDAQ Biotechnology ETF (IBB) plummeting 23% from 9/21/15 through Election Day this November. Why? Clinton was very vocal about her desire to slash what she believed to be excessive profits in the biotech industry. This would force drug companies to lower prices that would tighten margins and decrease net profit. If Clinton won the election, there were concerns that she would flip the Senate and/or House of Representatives to Democratic control. This would have allowed her to take action on the pricing practices of the biotech sector.

But with the White House and Congress now in Republican control, the biotech sector is set up for an extraordinary comeback. In fact, it has already begun. The IBB is up about 10% since Election Day. With Trump taking the White House, biotech investors could be in for one heck of a ride as this could be just the beginning of a move that could see the biotech sector double.

In an interview with Ken Kam of Forbes, Todd Hagopian said, “After underperforming the S&P 500 by over 30% in the past 14 months, there is plenty of room for this sector to run. In fact, the S&P 500 Biotechs are trading at a Forward P/E of just 22.4% vs. Consumer Staples who are trading at a Forward P/E of 17.2%.  This is pretty remarkable, considering that the same group of Biotech companies have a short term earnings growth rate of 17.3%, versus the Consumer Staple companies who are projected to grow at just 8.0%. Basically, this data would seem to suggest that either there is a huge bubble in Consumer Staples stocks, or the Biotechnology market is about to double.”

This is the perfect storm for cannabis biotech investors. Not only is the overall biotech industry expected to experience a massive bull run, but cannabis legalization is quickly spreading across the US. The November Election Day was an enormous victory for the cannabis industry. There are now 8 states that allow the recreational use of marijuana and another 21 that allow its medical use. We could be looking at a golden opportunity for cannabis biotech investors.

In his interview with Forbes, Hagopian went on to name a few other catalysts that biotech investors seem to have in their favor:

  1. The Obamacare fight needs to stay away from pricing. The odds of a Republican House and Senate trying to pass a law regulating drug prices, and have it signed by a Republican President seems slim to none.
  2. The Supreme Court needs to stay conservative. Donald Trump has already promised to nominate conservative judges to the court. The Supreme Court will likely stay 5-4, or even 6-3, in favor of conservative views.
  3. M&A activity needs to restart. The low valuations seen in the biotech sector after the Clinton selloff mentioned earlier in this article has sparked a ton of M&A rumors in the biotech sector. The Clinton biotech scare not only provided great opportunity for individual investors but also for large biotech titans to swallow up smaller companies with promising intellectual property and clinical data from early drug trials. We have already seen recent M&A activity in the cannabis sector with Canopy Growth Corp., Canada’s largest marijuana company, agreeing to buy competitor Mettrum Health Corp. for $8.42 a share.

The current environments of the overall biotech sector and marijuana industry have created an exciting time for cannabis biotech investors. Several catalysts are aligning for what could be a booming 2017 for the entire space. In addition, many companies are expected to announce FDA clinical and pre-clinical trial data soon. Favorable results will be a catalyst to send individual stocks and the overall cannabis biotech sector considerably higher.

If you haven’t done so already, it’s time to consider adding cannabis biotech to your portfolio, Now!

0 4105

Terra Tech Subsidiary Edible Garden to Participate in The New York Produce Show and Conference December 7th

Edible Garden will have an exhibit booth at the show displaying both new and existing products including its SUPERLEAF™ product and organic herbs. Following the Produce Show, Edible Garden will be rolling out its Living SUPERLEAF™ Spring Mix and Cut SUPERLEAF™ Spring Mix to existing Northeast supermarket customers.

Derek Peterson, Chairman and CEO of Terra Tech commented, “The New York Produce Show and Conference offers Edible Garden a prime opportunity to display and market the beneficial and nutritional properties of our organic SUPERLEAF™ lettuce to such a prospective audience. Our non-GMO verified SUPERLEAF™ lettuce continues to be a popular item for customers looking for enhanced nutritional benefits as one serving of this lettuce contains more than twice the amount of antioxidants as blueberries. The rollout of SUPERLEAF™ to existing customers in the Northeast will only expand our footprint as we aim to gain market share for Edible Garden and drive shareholder value.”

To be added to the Terra Tech email distribution list, please email TRTC@kcsa.com with TRTC in the subject line.

About Terra Tech

Terra Tech Corp. (TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Gardens, MediFarm LLC and GrowOp Technology. Blüm’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Blüm offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces medical cannabis-extracted products for regulated medical cannabis dispensaries throughout California. The Company’s wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Winn-Dixie, Raley’s, Meijer, Kroger, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest. Terra Tech’s MediFarm LLC subsidiaries are focused on medical cannabis cultivation and permitting businesses throughout Nevada. The Company’s wholly-owned subsidiary GrowOp Technology specializes in controlled environment agricultural technologies.

For more information about Terra Tech Corp visit: http://www.terratechcorp.com/
For more information about IVXX visit: http://ivxx.com/
For more information about Blüm Nevada visit: http://letsblum.com
For more information about Blüm Oakland visit: http://blumoak.com/
Visit us on Facebook @ https://www.facebook.com/terratechcorp/timeline
Follow us on Twitter @terratechcorp
Follow us on Instagram @socal_IVXX
For more information about Edible Garden visit: http://www.ediblegarden.com/
Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms?fref=ts
Visit IVXX on Facebook @ https://www.facebook.com/ivxxbrand?fref=ts

About The New York Produce Show and Conference

The four-day event, presented by PRODUCE BUSINESS magazine and the Eastern Produce Council, includes networking opportunities, a trade show of over 400 companies, retail “Thought-Leader” breakfast panel hosted by Perishable Pundit Jim Prevor, educational micro-sessions, ag and culinary student outreach and tours of the region’s vibrant industry, including the local retailers, wholesalers, foodservice distributors, urban farms and unique eateries. www.nyproduceshow.com

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements